Literature DB >> 17605805

Renal-hepatic-pancreatic dysplasia syndrome (Ivemark's syndrome).

Mahesha Vankalakunti1, Kirti Gupta, Nandita Kakkar, Ashim Das.   

Abstract

BACKGROUND: Renal-Hepatic-Pancreatic dysplasia syndrome described by Ivemark in 1959 constitutes a triad pancreatic fibrosis, renal dysplasia and hepatic dysgenesis. CASE
PRESENTATION: We describe two unrelated cases of Renal-Hepatic-Pancreatic dysplasia syndrome in stillborn babies. The characteristic microscopic features were present in both the cases. The second case illustrates the unique association lymphangiectasia with Renal-Hepatic-Pancreatic dysplasia syndrome. Both cases are unrelated and there is no history of any consanguineous marriage.
CONCLUSION: These two cases are unrelated and are rare. In the developmental research, the perinatal autopsy needs to be utilized as a major tool and an Ad hoc committee formation is required to formulate the approach towards syndromic diseases.

Entities:  

Year:  2007        PMID: 17605805      PMCID: PMC1919354          DOI: 10.1186/1746-1596-2-24

Source DB:  PubMed          Journal:  Diagn Pathol        ISSN: 1746-1596            Impact factor:   2.644


  13 in total

1.  Familial dysplasia of kidneys, liver and pancreas: a probably genetically determined syndrome.

Authors:  B I IVEMARK; V OLDFELT; R ZETTERSTROM
Journal:  Acta Paediatr       Date:  1959-01       Impact factor: 2.299

2.  Ivemark's renal-hepatic-pancreatic dysplasia: analytic approach to a perinatal autopsy.

Authors:  R W Bendon
Journal:  Pediatr Dev Pathol       Date:  1999 Jan-Feb

3.  A syndrome of multiple developmental defects including polycystic kidneys and intrahepatic biliary dysgenesis in 2 siblings.

Authors:  D W Smith; J M Opitz; S L Inhorn
Journal:  J Pediatr       Date:  1965-10       Impact factor: 4.406

4.  ADP-ribosylation factor-like 3 is involved in kidney and photoreceptor development.

Authors:  Jeffrey J Schrick; Peter Vogel; Alejandro Abuin; Billy Hampton; Dennis S Rice
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

Review 5.  The Ivemark syndrome: prenatal diagnosis of an uncommon cystic renal lesion with heterogeneous associations.

Authors:  R S Larson; M A Rudloff; H Liapis; J L Manes; R Davila; J Kissane
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

6.  Ontogeny of renal dysplasia in Ivemark syndrome: light and immunohistochemical characterization.

Authors:  R Abbi; F Daum; E Kahn
Journal:  Ann Clin Lab Sci       Date:  1999 Jan-Mar       Impact factor: 1.256

7.  Glutaric acidemia type II. Comparison of pathologic features in two infants.

Authors:  A D Colevas; J L Edwards; R H Hruban; G A Mitchell; D Valle; G M Hutchins
Journal:  Arch Pathol Lab Med       Date:  1988-11       Impact factor: 5.534

8.  Dysplasia of the kidneys, liver, and pancreas: report of a variant of Ivemark's syndrome.

Authors:  D S Strayer; J M Kissane
Journal:  Hum Pathol       Date:  1979-03       Impact factor: 3.466

9.  Polycystic disease of kidney, liver and pancreas; a possible patholgenesis.

Authors:  J E Mcgeoch; E M Darmady
Journal:  J Pathol       Date:  1976-08       Impact factor: 7.996

10.  Renal-pancreatic-hepatic dysplasia in siblings.

Authors:  D L Blowey; B A Warady; D L Zwick; C Ong
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

View more
  3 in total

1.  Failure to Thrive, Jaundice, and Polyuria in Early Infancy: Common Presentation with an Uncommon Lethal Etiology.

Authors:  Sonia Sharma
Journal:  J Pediatr Genet       Date:  2019-11-11

Review 2.  Prenatal genetic considerations of congenital anomalies of the kidney and urinary tract (CAKUT).

Authors:  Asha N Talati; Carolyn M Webster; Neeta L Vora
Journal:  Prenat Diagn       Date:  2019-08-05       Impact factor: 3.050

Review 3.  Evidence for a "Pathogenic Triumvirate" in Congenital Hepatic Fibrosis in Autosomal Recessive Polycystic Kidney Disease.

Authors:  Lu Jiang; Pingping Fang; James L Weemhoff; Udayan Apte; Michele T Pritchard
Journal:  Biomed Res Int       Date:  2016-11-07       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.